|
Market Closed -
Nasdaq
16:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 1.930 USD | +6.63% |
|
-8.10% | -73.78% |
| 08-13 | Karyopharm Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-13 | Karyopharm Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Biopharmaceuticals | +6.63% | -8.10% | -73.78% | -65.47% | -97.28% | 43.78M |  | | |
- Stock Market
- Stocks
- KPTI Stock
- Charts Karyopharm Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
